Calyxt Reports Fourth Quarter and Full Year 2021 Financial R

/PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced financial results for its fourth quarter and full year...

Related Keywords

Minnesota , United States , Canada , Vijay Gullapalli , Kimberly Minarovich Cameron Willis , Gerry Nuovo , Seth Dobrin , Dan Voytas , Michaela Carr , Calyxt Inc , Technology Platform , Ibm , Nasdaq , Calyxt Business Development Contact , Payroll Protection Program , Company Annual Report On Form , Company As Vice , Company Paycheck Protection Program , Technology Licensing Leader , Innovation At Darling Ingredients Inc , Toll International , International Replay Number , Company Biofactory , Company As Senior Vice , Business Development , Chief Executive Officer , Scientific Advisory Board , Production System , Vice President , Darling Ingredients , Senior Vice President , Data Science , Pete Ball , Global Chief Artificial Intelligence , Three Months Ended December , Fiscal Year , Paycheck Protection Program , Bill Koschak , Chief Financial , Full Year , Chief Financial Officer , Free Replay Number , Replay Number , Plant Cell Matrix , Media Contact , Investor Relations Contact , Cameron Willis , Business Development Contact , Payroll Protection , Securities Litigation Reform Act , Annual Report , Except Par Value , Share Amounts , Thousands Except Shares , Per Share Amounts , Ended December , Calyxt , Nc ,